Comparison Between Brainlab Knee 3 Computer-assisted Navigation Systems and Conventional Instruments in TKA: a Prospective Cohort Study.
4 de julio de 2021 actualizado por: Peking University Third Hospital
Comparison of Accuracy and Clinical Outcomes Between Brainlab Knee 3 Computer-assisted Navigation Systems and Conventional Instruments in TKA: a Prospective Cohort Study
This is a a prospective cohort study.
According to the inclusion criteria, volunteers were recruited from patients undergoing total knee arthroplasty.
The patients are devided into two groups: the conventional TKA,the computer-assisted surgery(CAS) using Brainlab Knee 3 system.The differences of postoperative alignment,operative time,blood loss will be studied between the two groups.Clinical and functional evaluation using the scoring system of HSS(Hospital for Special Surgery) score, Western Ontario and McMaster University osteoarthritis index (WOMAC), Forgotten joint score(FJS-12) will be compared between the 2 groups,after surgery, and at the follow-up of 3 months、6 months and 12 months.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Descripción detallada
According to the inclusion criteria, patients receiving primary total knee arthroplasty were recruited and divided into two groups after doctor-patient joint decision: the traditional group underwent prosthesis placement using traditional intramedullary positioning method;The navigation group performed surgery using the Brainlab Knee 3 navigation system.Informed consent was signed after grouping.
All patients were operated by the same knee prosthesis system.
Both groups underwent the same procedures such as the installation of the soft tissue adjustment, prosthesis placement, wound closure and so on.All patients were given the same perioperative treatment, such as hemostasis, anti-infection and analgesia, and routine postoperative rehabilitation exercises.
The full length anteroposterior and lateral radiographs of both lower extremities in weight-bearing position were taken preoperatively and one week postoperatively.The differences of postoperative alignment,operative time,blood loss will be studied between the two groups.Clinical and functional evaluation using the scoring system of HSS(Hospital for Special Surgery) score, Western Ontario and McMaster University osteoarthritis index (WOMAC), Forgotten joint score(FJS-12) will be compared between the 2 groups,after surgery, and at the follow-up of 3 months、6 months and 12 months.
Tipo de estudio
De observación
Inscripción (Anticipado)
188
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Hua Tian
- Número de teléfono: 13511065187
- Correo electrónico: tianhua@bjmu.edu.cn
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
40 años a 80 años (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Todos
Método de muestreo
Muestra no probabilística
Población de estudio
Patients with knee osteoarthritis who underwent primary TKA
Descripción
Inclusion criteria:
- Patients with knee osteoarthritis who underwent primary TKA;
- Informed consent has been signed and medical records are complete;
- No severe varus or valgus deformity of the knee (< 20°).
Exclusion criteria:
- Patients undergoing revision knee replacement;
- patients with rheumatoid arthritis and secondary knee osteoarthritis;
- Patients with severe valgus deformity(≥ 20°);
- Taking anticoagulant drugs for a long time in the past, or suffering from the following diseases: Renal insufficiency, liver insufficiency, severe heart disease (or coronary stent implantation within the last 12 months), severe respiratory disease, history of deep vein thrombosis in the lower extremities or a high risk of thrombosis (hereditary/acquired thrombosis), coagulation dysfunction, stroke, and malignancy
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
The traditional group
The traditional group underwent prosthesis placement using traditional intramedullary positioning method.
|
|
|
The navigation group
The navigation group performed surgery using the Brainlab Knee 3 navigation system.Informed consent was signed after grouping.
|
Brainlab knee 3 navigation system is a kind of imageless computer-assisted navigation system.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
lower limb alignment
Periodo de tiempo: Within 1 week after surgery
|
knee-ankle angle (HKA) and components placement using coronal femoral-component angle (CFA) and coronal tibia- component angle (CTA)、sagittal femoral-component angle (SFA) and sagittal tibia-component angle（STA）.
|
Within 1 week after surgery
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Operation time
Periodo de tiempo: Immediately after surgery
|
Time from skin incision to wound closure.
|
Immediately after surgery
|
|
Blood loss
Periodo de tiempo: 3 days after surgery
|
Postoperative drainage volume refers to the drainage volume of the affected knee within 24 hours after the end of surgery, accurate to ml.Gross linear equation was used to calculate the total blood loss and latent blood loss at 3 days after surgery.
|
3 days after surgery
|
|
the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Periodo de tiempo: 3 months、6 months and 12 months after surgery
|
The WOMAC is a self administered questionnaire to assess joint function and quality of life for patients with osteoarthritis; it consists of 24 items: pain (5 items), stiffness (2 items), and physical function (17 items).
The higher the total score, the worse the patient's pain, stiffness, and functional limitations.
The WOMAC is validated for various languages, including Chinese.
|
3 months、6 months and 12 months after surgery
|
|
HSS(Hospital for Special Surgery) score
Periodo de tiempo: 6 months and 12 months after surgery
|
HSS(hospital for special surgery) score HSS(hospital for special surgery) score to evaluate patients postoperative knee joint function.
With a total of 100, it has 7 subscales: 1.Pain 0~30; 2. Function 0~22; 3. Mobility 0~18; 4. Flexion deformity 0~10; 6. Stability 0~10; 7. Deduction Item.
For each scale, a higher value represents a better outcome.
The sum of the subscales is the total score.
|
6 months and 12 months after surgery
|
|
Forgotten Joint Score-12 (FJS-12)
Periodo de tiempo: 6 months and 12 months after surgery
|
The FJS-12 is a PROM for patients who have undergone a TKA; it introduces the concept of a "forgotten" joint as the ideal objective to pursue in prosthetic surgery.
It is composed of 12 items, measuring the patient's ability to forget the presence of an artificial joint in their daily life.
For each item, there is a five-points Likert scale response.
The raw results are converted to a 0-100 points scale.
Highest score corresponds to good outcome with the patient not aware about the presence of the prosthesis.
In the case of more than 4 answers are missing, the score should not be used .
|
6 months and 12 months after surgery
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Anticipado)
1 de enero de 2022
Finalización primaria (Anticipado)
31 de diciembre de 2022
Finalización del estudio (Anticipado)
31 de diciembre de 2023
Fechas de registro del estudio
Enviado por primera vez
4 de julio de 2021
Primero enviado que cumplió con los criterios de control de calidad
4 de julio de 2021
Publicado por primera vez (Actual)
13 de julio de 2021
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
13 de julio de 2021
Última actualización enviada que cumplió con los criterios de control de calidad
4 de julio de 2021
Última verificación
1 de julio de 2021
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- navigation68480
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
producto fabricado y exportado desde los EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .